CMS
Robocall for Testing Fraud
The Pittsburgh Post-Gazette warns that a robocall is offering free genetic testing for cancer or heart disease as part of a Medicare scam.
For Negotiation
President Biden is urging lawmakers to pass legislation to enable Medicare to negotiate drug prices directly with companies, the Washington Post says.
Biocept HER2 Assay Gains Coverage Under Medicare Local Coverage Determination for CTC Tests
Under the LCD, CTC assays, such as Biocept's, will now be covered to guide targeted treatment decisions for patients with breast and other cancers under certain circumstances.
US House Appropriations Committee Seeks 15 Percent NIH Funding Increase for Fiscal 2022
The House committee called for an additional $3.5 billion for all existing NIH institutes and centers, with an increase of no less than 5 percent for each.
Could Cost Billions
NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.